Alicante Phase I Clinical Trials Unit (UECA)

Support and advisory platform for the design of clinical trials and clinical studies, through the evaluation and analysis of preclinical data, data collection and management, study monitoring, project preparation and submission, and the dissemination and publication of research results.

• Support and advisory services in the design of clinical trials and clinical studies in general. Methodological, statistical, ethical, and quality design and analysis of clinical trials.
• Advisory services for the selection and application of new drugs.
• Evaluation and analysis of preclinical data.
• Clinical trials and clinical studies in humans in their different phases (I, II, III, and IV) and modalities (pharmacokinetic–pharmacodynamic trials, bioequivalence studies and first‑in‑human trials, interaction studies, trials in special populations, post‑marketing efficacy and safety studies, pharmacovigilance, pharmacoeconomic, and pharmacogenetic studies).
• Collection and management of clinical study data.
• Monitorización de estudios clínicos.
• Preparation and submission of projects to public calls.
• Difusión y publicación de resultados de investigación.
• Expert reports and collaboration with the pharmaceutical industry in meeting regulatory and administrative requirements.